Stay updated on Margetuximab Combo in Chinese HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link has been removed.
    Difference
    0.8%
    Check dated 2025-09-14T09:53:21.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The page has updated the status of Zai Lab (Hong Kong), Ltd. to 'Unknown status' and revised the version number from v3.0.0 to v3.0.1.
    Difference
    5%
    Check dated 2025-09-07T07:47:51.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while removing specific details about states, cities, and previously listed location countries.
    Difference
    10%
    Check dated 2025-08-31T00:59:32.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-16T18:55:23.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.3%
    Check dated 2025-08-09T14:57:20.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.16.10) and the status of Zai Lab (Hong Kong), Ltd. is now listed as 'Unknown'.
    Difference
    8%
    Check dated 2025-08-02T13:55:33.000Z thumbnail image

Stay in the know with updates to Margetuximab Combo in Chinese HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab Combo in Chinese HER2+ MBC Clinical Trial page.